Stock Events

Stock Events

PharmaRoth Labs 

$0
8
+$0+0% Thursday 21:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
20,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

31MarExpected
Q1 2016
Q3 2016
Q4 2016
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0001

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ROTH. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with PharmaRoth Labs in the development and marketing of medications for various diseases, including those PharmaRoth targets.
Merck
MRK
Mkt Cap214.76B
Merck operates in the same pharmaceutical and healthcare sectors as PharmaRoth Labs, offering competitive products in the therapeutic areas PharmaRoth is involved in.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division, competes directly with PharmaRoth Labs in the research, development, and sale of pharmaceutical products.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes with PharmaRoth Labs in the biopharmaceutical field, focusing on drugs for conditions that PharmaRoth may also be targeting.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes with PharmaRoth Labs in the development and marketing of drugs for infectious diseases, a potential area of focus for PharmaRoth.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology firm that competes with PharmaRoth Labs in developing innovative therapies, possibly in overlapping disease areas.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that competes with PharmaRoth Labs in several therapeutic areas, including cancer and cardiovascular diseases.
Novartis
NVS
Mkt Cap237.61B
Novartis is a multinational pharmaceutical company that competes with PharmaRoth Labs across a broad range of therapeutic areas, including those PharmaRoth may target.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global healthcare company that competes with PharmaRoth Labs in the development of medications for various diseases, potentially overlapping with PharmaRoth’s focus areas.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a biopharmaceutical company that competes with PharmaRoth Labs in developing and marketing drugs for several diseases, including those in PharmaRoth’s portfolio.

About

PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.
Show more...
CEO
Mr. Luis Manuel Ornelas Lopez
Country
US
ISIN
US71715Y1029

Listings

OTC Link
US
ROTH

0 Comments

Share your thoughts

FAQ

What is PharmaRoth Labs stock price today?▼
The current price of ROTH is $0 USD — it has increased by +0% in the past 24 hours. Watch PharmaRoth Labs stock price performance more closely on the chart.
What is PharmaRoth Labs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange PharmaRoth Labs stocks are traded under the ticker ROTH.
What were PharmaRoth Labs earnings last quarter?▼
ROTH earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
When did PharmaRoth Labs complete a stock split?▼
The last stock split for PharmaRoth Labs was on June 01, 2010 with a ratio of 5:1.
Where is PharmaRoth Labs headquartered?▼
PharmaRoth Labs is headquartered in Las Vegas, US.